The Role of Fungi in the Diagnosis of Colorectal Cancer

Overview

Journal Mycology

Date 2024 Apr 1

PMID 38558845

Authors

Xu-Huan Li

Ming-Ming Luo

Zu-Xiu Wang

Qi Wang

Bin Xu

Affiliations

Soon will be listed here.

Abstract

Colorectal cancer (CRC) is a prevalent tumour with high morbidity rates worldwide, and its incidence among younger populations is rising. Early diagnosis of CRC can help control the associated mortality. Fungi are common microorganisms in nature. Recent studies have shown that fungi may have a similar association with tumours as bacteria do. As an increasing number of tumour-associated fungi are discovered, this provides new ideas for the diagnosis and prognosis of tumours. The relationship between fungi and colorectal tumours has also been recently identified by scientists. Therefore, this paper describes the limitations and prospects of the application of fungi in diagnosing CRC and predicting CRC prognosis.

Citing Articles

Intraneoplastic fungal dysbiosis is associated with colorectal cancer progression and host gene mutation.

Yuan K, Xu H, Li S, Coker O, Liu W, Wang L EBioMedicine. 2025; 113:105608.

PMID: 39970705 PMC: 11876754. DOI: 10.1016/j.ebiom.2025.105608.

References

Zheng X, Wang R, Zhang X, Sun Y, Zhang H, Zhao Z . A deep learning model and human-machine fusion for prediction of EBV-associated gastric cancer from histopathology. Nat Commun. 2022; 13(1):2790. PMC: 9120175. DOI: 10.1038/s41467-022-30459-5. View

Rebersek M . Gut microbiome and its role in colorectal cancer. BMC Cancer. 2021; 21(1):1325. PMC: 8666072. DOI: 10.1186/s12885-021-09054-2. View

Barbosa A, Miranda S, Azevedo N, Cerqueira L, Azevedo A . Imaging biofilms using fluorescence hybridization: seeing is believing. Front Cell Infect Microbiol. 2023; 13:1195803. PMC: 10239779. DOI: 10.3389/fcimb.2023.1195803. View

Coker O, Nakatsu G, Dai R, Wu W, Wong S, Ng S . Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer. Gut. 2018; 68(4):654-662. PMC: 6580778. DOI: 10.1136/gutjnl-2018-317178. View

Liang J, Li T, Nakatsu G, Chen Y, Yau T, Chu E . A novel faecal marker for the non-invasive diagnosis of colorectal adenoma and cancer. Gut. 2019; 69(7):1248-1257. PMC: 7306980. DOI: 10.1136/gutjnl-2019-318532. View

Nel Van Zyl K, Whitelaw A, Hesseling A, Seddon J, Demers A, Newton-Foot M . Fungal diversity in the gut microbiome of young South African children. BMC Microbiol. 2022; 22(1):201. PMC: 9387017. DOI: 10.1186/s12866-022-02615-w. View

Lin Y, Lau H, Liu Y, Kang X, Wang Y, Ting N . Altered Mycobiota Signatures and Enriched Pathogenic Aspergillus rambellii Are Associated With Colorectal Cancer Based on Multicohort Fecal Metagenomic Analyses. Gastroenterology. 2022; 163(4):908-921. DOI: 10.1053/j.gastro.2022.06.038. View

Fassarella M, Blaak E, Penders J, Nauta A, Smidt H, Zoetendal E . Gut microbiome stability and resilience: elucidating the response to perturbations in order to modulate gut health. Gut. 2020; 70(3):595-605. DOI: 10.1136/gutjnl-2020-321747. View

Elmallah M, Ortega-Deballon P, Hermite L, Pais-de-Barros J, Gobbo J, Garrido C . Lipidomic profiling of exosomes from colorectal cancer cells and patients reveals potential biomarkers. Mol Oncol. 2022; 16(14):2710-2718. PMC: 9298677. DOI: 10.1002/1878-0261.13223. View

10.

Clay S, Fonseca-Pereira D, Garrett W . Colorectal cancer: the facts in the case of the microbiota. J Clin Invest. 2022; 132(4). PMC: 8843708. DOI: 10.1172/JCI155101. View

11.

Debeljak P, Baltar F . Fungal Diversity and Community Composition across Ecosystems. J Fungi (Basel). 2023; 9(5). PMC: 10219167. DOI: 10.3390/jof9050510. View

12.

Bilal H, Shafiq M, Hou B, Islam R, Khan M, Khan R . Distribution and antifungal susceptibility pattern of species from mainland China: A systematic analysis. Virulence. 2022; 13(1):1573-1589. PMC: 9487756. DOI: 10.1080/21505594.2022.2123325. View

13.

Stasiewicz M, Karpinski T . The oral microbiota and its role in carcinogenesis. Semin Cancer Biol. 2021; 86(Pt 3):633-642. DOI: 10.1016/j.semcancer.2021.11.002. View

14.

Patel S, Karlitz J, Yen T, Lieu C, Boland C . The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol Hepatol. 2022; 7(3):262-274. DOI: 10.1016/S2468-1253(21)00426-X. View

15.

Anderson J, Robinson C, Hisey W, Edwards D, Kneedler B, Berger B . Colorectal Neoplasia Detection in Individuals With Positive Multitarget Stool DNA Tests: Data From the New Hampshire Colonoscopy Registry. J Clin Gastroenterol. 2021; 56(5):419-425. DOI: 10.1097/MCG.0000000000001554. View

16.

Ballester M, Mesonero F, Florez-Diez P, Gomez C, Fuentes-Valenzuela E, Martin N . Adherence to endoscopic surveillance for advanced lesions and colorectal cancer in inflammatory bowel disease: an AEG and GETECCU collaborative cohort study. Aliment Pharmacol Ther. 2022; 55(11):1402-1413. DOI: 10.1111/apt.16832. View

17.

Strickland A, Shi M . Mechanisms of fungal dissemination. Cell Mol Life Sci. 2021; 78(7):3219-3238. PMC: 8044058. DOI: 10.1007/s00018-020-03736-z. View

18.

Kong W, Machida R . Development of transcriptomics-based growth rate indices in two model eukaryotes and relevance to metatranscriptomics datasets. Mol Ecol Resour. 2022; 22(7):2627-2639. PMC: 9545445. DOI: 10.1111/1755-0998.13652. View

19.

Yuan B, Ma B, Yu J, Meng Q, Du T, Li H . Fecal Bacteria as Non-Invasive Biomarkers for Colorectal Adenocarcinoma. Front Oncol. 2021; 11:664321. PMC: 8383742. DOI: 10.3389/fonc.2021.664321. View

20.

Kamel F, Eltarhoni K, Nisar P, Soloviev M . Colorectal Cancer Diagnosis: The Obstacles We Face in Determining a Non-Invasive Test and Current Advances in Biomarker Detection. Cancers (Basel). 2022; 14(8). PMC: 9029324. DOI: 10.3390/cancers14081889. View